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Introduction {#sec1}
============

Nucleotide second messengers are crucial intracellular signals in all domains of life. In bacteria, one of the most widespread nucleotide second messengers is 3′,5′-cyclic diguanylic acid (c-di-GMP), which regulates diverse global cellular processes that allow bacteria to respond rapidly to dynamic environmental conditions ([@bib51]). Levels of intracellular c-di-GMP are determined by the action of diguanylate cyclases (DGCs), which are characterized by active site GGDEF motifs that synthesize c-di-GMP from two molecules of GTP ([@bib78], [@bib16]) and by c-di-GMP hydrolyzing phosphodiesterases (PDEs), characterized by EAL or HD-GYP domains ([@bib90], [@bib21], [@bib83]). DGCs and PDEs are often associated with sensory domains, which allow the cell to adjust c-di-GMP levels in direct response to specific environmental stimuli ([@bib42]).

Although DGCs and PDEs conform to a few well-conserved structural classes ([@bib87], [@bib69]) and can be identified bioinformatically, the downstream targets of c-di-GMP signaling are structurally diverse, with multiple protein and RNA folds shown to bind c-di-GMP ([@bib20]). The first c-di-GMP-binding effectors to be identified included degenerate (non-catalytic) GGDEF or EAL proteins ([@bib73], [@bib74], [@bib28], [@bib60], [@bib79]), c-di-GMP-specific GEMM riboswitches ([@bib101]), and the PilZ domain ([@bib5], [@bib85]), which is involved in the regulation of a wide range of cellular processes, including motility in *E. coli* ([@bib9]) and cellulose synthesis in *Komagataeibacter xylinus* (formerly *Acetobacter xylinum*), the system where c-di-GMP was first discovered ([@bib82], [@bib72]). Subsequent biochemical screens for c-di-GMP-binding effectors have identified the ATPase domains of functionally diverse proteins ([@bib68], [@bib102], [@bib81], [@bib70]), a membrane transporter ([@bib100]), a histidine kinase ([@bib27]), and the ribosome-modifying enzyme RimK ([@bib66]).

Transcription factors represent a particularly varied subset of c-di-GMP effector proteins and include Crp family members ([@bib59], [@bib19], [@bib30]), TetR-like proteins ([@bib62], [@bib64], [@bib65]), the NtrC-like protein VspR from *Vibrio cholerae* ([@bib98]), and AAA+ ATPases ([@bib7], [@bib99], [@bib94], [@bib70]). The diverse c-di-GMP-responsive transcription factors for which structural information is available and c-di-GMP binding is understood include VpsT, which is a member of the FixJ/LuxR/CsgD family of response regulators ([@bib55]); the AAA+ ATPase enhancer-binding protein FleQ, which acts as a master regulator of flagellar motility in *Pseudomonas* ([@bib70]); *K. pneumoniae* MrkH, a PilZ transcription regulator of biofilm formation ([@bib91], [@bib107]); the MerR family member BrlR ([@bib15], [@bib80]); and BldD, the master regulator of development in *Streptomyces* ([@bib105]). There is no significant conservation between the c-di-GMP binding motifs found in different c-di-GMP effector proteins, rendering bioinformatic identification not possible. As a result, new c-di-GMP effectors, most notably transcription regulators, must be identified experimentally.

In Gram-negative bacteria, the responses mediated by cellular c-di-GMP levels include virulence, motility, and biofilm formation ([@bib51]). In contrast, less is known about the role of c-di-GMP in Gram-positive bacteria. However, we recently showed that, in the filamentous Gram-positive bacteria *Streptomyces*, c-di-GMP controls initiation of development ([@bib105], [@bib10]). *Streptomyces* are ubiquitous, primarily soil-dwelling bacteria with a complicated developmental life cycle involving progression from vegetative growth to production of reproductive aerial hyphae that differentiate into chains of exospores ([@bib32], [@bib34], [@bib71], [@bib10]). Entry into development coincides with biosynthesis of numerous secondary metabolites that serve as our most abundant source of clinically important antibiotics and provide other medically important drugs, such as anticancer agents and immunosuppressants ([@bib46], [@bib67], [@bib106]). Consequently, there is considerable interest in understanding the mechanisms that control this developmental transition. The controlling transcription factors of the *Streptomyces* sporulation regulatory network are encoded by the *bld* and the *whi* loci ([@bib32], [@bib34], [@bib71], [@bib10]). Mutations in *bld* genes prevent production of reproductive aerial hyphae, resulting in "bald" colonies lacking the fuzzy appearance of the wild type (WT). Mutations in *whi* genes prevent reproductive aerial hyphae differentiating into mature spore chains, producing "white" colonies because they fail to synthesize the green polyketide pigment associated with fully developed spores.

The dramatic phenotypic consequences of altered c-di-GMP levels in *Streptomyces*, where high c-di-GMP levels trap the bacteria in vegetative growth and low c-di-GMP levels cause precocious hypersporulation ([@bib105], [@bib104], [@bib4], [@bib25], [@bib103], [@bib50], [@bib10], [@bib58]), suggested that this signaling molecule must directly interact with the regulatory network controlling the life cycle. In 2014, a direct link between c-di-GMP and the regulatory cascade was established with the discovery that the master regulator BldD is a c-di-GMP effector protein ([@bib105]). BldD is a repressor that sits at the top of the developmental regulatory network, serving to repress a large set of genes, including many genes of the core transcriptional regulatory cascade itself ([@bib25], [@bib105], [@bib10]). Structural and biochemical analyses showed that BldD dimerization and, hence, its ability to bind DNA depends on the binding of a novel tetrameric form of c-di-GMP to the C-terminal domain (CTD) of the protein ([@bib105], [@bib92]).

These data showed that BldD-c-di-GMP controls the onset of development. By contrast, what controls the final stage of development, differentiation of the reproductive aerial hyphae into spores, has been unknown. The sporulation-specific σ factor σ^WhiG^ is known to play a key role in this stage of development ([@bib33], [@bib17]), but its function has not been subjected to systematic analysis. Here we identify a novel anti-σ factor, RsiG, that controls the activity of σ^WhiG^. Strikingly, we show that the interaction between RsiG and σ^WhiG^ is mediated by c-di-GMP. Specifically, when "armed" with a dimer of c-di-GMP, RsiG sequesters σ^WhiG^, blocking differentiation of the reproductive hyphae into spores. This is the first known instance of c-di-GMP targeting a σ factor. Thus, like BldD, the RsiG-σ^WhiG^ complex senses changes in c-di-GMP levels to control a specific stage of development. In this complex, RsiG primarily binds the cyclic dinucleotide via two E(X)~3~S(X)~2~R(X)~3~Q(X)~3~D signatures, one on each helix of its antiparallel coiled coil. This signature is distinct from any previously observed c-di-GMP binding motif. Notably, the anti-σ factor RsiG can bind c-di-GMP in the absence of σ^WhiG^, and that binding is specific for this nucleotide. We also show that RsiG must bind c-di-GMP to carry out its function of inhibiting σ^WhiG^ activity during vegetative growth, preventing premature expression of the σ^WhiG^ regulon. Conservation of the signature c-di-GMP binding motifs in all *Streptomyces* RsiG homologs suggests that regulation of RsiG-σ^WhiG^ complex formation by this second messenger is a general mechanism of developmental control across the genus.

Results {#sec2}
=======

σ^WhiG^ Levels Are Critical to the Developmental Fate of Hyphae in *Streptomyces venezuelae* {#sec2.1}
--------------------------------------------------------------------------------------------

One factor known to be important in the later stages of *Streptomyces* development is the sporulation-specific σ factor σ^WhiG^. In particular, this σ factor has been shown previously to play a key role in the differentiation of reproductive hyphae into spores in the classical model species *Streptomyces coelicolor* ([@bib33], [@bib17]), but its function had not been subjected to systematic analysis. Thus, to interrogate the function of σ^WhiG^, we first examined the phenotypes associated with deletion and overexpression of *whiG* in *Streptomyces venezuelae*. We adopted *S. venezuelae* as a new model species to interrogate development because, unlike *S. coelicolor*, which differentiates only on plates, *S. venezuelae* also sporulates in a liquid medium ([@bib10], [@bib88]). A constructed *ΔwhiG* null mutant was unable to synthesize the green polyketide spore pigment associated with WT *S. venezuelae* spores, resulting in a classic white phenotype ([Figure 1](#fig1){ref-type="fig"}A). In *S. coelicolor*, *ΔwhiG* mutants fail to initiate sporulation septation, producing undifferentiated aerial hyphae ([@bib33], [@bib17]), but the equivalent *S. venezuelae ΔwhiG* mutant showed an oligosporogenous phenotype, producing a mixture of undifferentiated aerial hyphae and occasional immature spore chains ([Figure 1](#fig1){ref-type="fig"}B). Conversely, overexpressing *whiG* in *S. venezuelae* using a strong constitutive promoter (*ermE^∗^*) caused a hypersporulation phenotype in which the vegetative hyphae differentiated into spore chains. As a consequence, the biomass of the resulting mature colonies consisted almost entirely of spores ([Figure 1](#fig1){ref-type="fig"}B), and the colonies appeared bald to the naked eye because aerial mycelium formation had been bypassed. This hypersporulation phenotype was equally apparent in time-lapse images of the *whiG* overexpression strain differentiating in a microfluidic device (see below).Figure 1Overexpression of *whiG* Causes Hypersporulation on Solid Medium(A) The phenotypes of WT *S. venezuelae*, the *whiG* mutant, the complemented *whiG* mutant, WT *S. venezuelae* overexpressing *whiG*, and strains carrying the corresponding empty vectors, photographed after 4 days of growth on Mannitol Yeast Extract Malt Extract (MYM) medium.(B) Scanning electron micrographs of the same strains imaged after 4 days of growth on MYM medium.See also [Figure S1](#mmc1){ref-type="supplementary-material"} and [Video S2](#mmc3){ref-type="supplementary-material"} for the effect of overexpressing *whiG* on sporulation in liquid culture.

σ^WhiG^ Functions to Activate Transcription of *whiH* and *whiI* {#sec2.2}
----------------------------------------------------------------

To identify genes that are directly activated by σ^WhiG^, we used a combination of genome-wide σ^WhiG^ chromatin immunoprecipitation sequencing (ChIP-seq) and transcriptional profiling of WT *S. venezuelae* and the *ΔwhiG* mutant. We found that σ^WhiG^ controls three target genes: the key late developmental regulatory genes *whiH* (*vnz27205*) and *whiI* (*vnz28820*), which have been identified previously as σ^WhiG^ targets in *S. coelicolor* ([@bib84], [@bib2]), and a third gene encoding a membrane protein of unknown function (*vnz15005*) ([Figure 2](#fig2){ref-type="fig"}). Time-resolved transcription profiling of differentiating cultures of WT *S. venezuelae* and the *whiG* null mutant showed that expression of *whiI* and *vnz15005* depends completely on *whiG*, whereas expression of *whiH* is partially dependent on *whiG* ([Figure 2](#fig2){ref-type="fig"}B). Despite its role in controlling sporulation in *Streptomyces*, phylogenetically σ^WhiG^ belongs to a clade of σ factors that control flagellum biosynthesis in diverse motile bacteria, including σ^28^ (also called σ^FliA^) in enteric bacteria and σ^D^ in *Bacillus subtilis* ([@bib17], [@bib49], [@bib41]). The −10 and −35 promoter sequences of *S. venezuelae whiH*, *whiI*, and *vnz15005* ([Figure 2](#fig2){ref-type="fig"}C) show clear similarity to the consensus sequences of these true flagellar σ factors.Figure 2The σ^WhiG^ Regulon(A) ChIP-seq data for the three σ^WhiG^ target genes *whiH*, *whiI*, and *vnz15005*. The plots span approximately 3 kb of DNA sequence. Genes running from right to left are shown in red, and genes running from left to right are shown in green. The black arrow indicates the genes transcribed by Eσ^WhiG^.(B) Transcriptional expression profiles of *whiH*, *whiI*, and *vnz15005* in WT *S. venezuelae* and in the congenic *whiG* null mutant during submerged sporulation. In each panel, the x axis indicates the age of the culture in hours, and the y axis indicates the normalized transcript abundance (log~2~).(C) Sequence alignment of σ^WhiG^ target promoters and comparison with the consensus sequence for true flagellar σ factors ([@bib39]). Transcription start sites (TSSs), shown in green, were determined as part of a genome-wide TSS mapping experiment. Putative −10 and −35 sequences are shown in red. Note that the spacing between the putative -10 and -35 sequences of the σ^WhiG^ target promoters is N16, while it is N15 for true flagellar σ factors.

A mutant deleted for the uncharacterized σ^WhiG^ target gene, *vnz15005*, had no detectable phenotype. In addition, although *whiH* and *whiI* are present in more than 98% of the 802 complete and annotated *Streptomyces* genomes available at GenBank (<https://www.ncbi.nlm.nih.gov/genbank/>), homologs of *vnz15005* are present in only 34%. These results suggest that the main function of σ^WhiG^ is to activate expression of *whiH* and *whiI*. To test this hypothesis, we placed *whiH* and *whiI* under control of the constitutive *ermE^∗^* promotor. When *whiH* and *whiI* were overexpressed together in the *ΔwhiG* mutant, it caused a hypersporulation phenotype identical to the effect of overexpressing *whiG* in WT *S. venezuelae* ([Figure 3](#fig3){ref-type="fig"}). This experiment provides strong evidence that the main function of σ^WhiG^ is to direct transcription of just two targets, the genes encoding the key late developmental regulators WhiI and WhiH. WhiI is an orphan response regulator that is essential for the late stages of sporulation, when it forms a functional heterodimer with a second orphan response regulator, BldM, enabling WhiI to bind to DNA and regulate the expression of ∼40 sporulation genes ([@bib3]). WhiH is a GntR-family transcriptional regulator that also controls a large regulon of late sporulation genes (unpublished data). Thus, σ^WhiG^ indirectly activates expression of more than 100 late sporulation genes via WhiH and WhiI.Figure 3Overexpression of *whiH* and *whiI* Together Recapitulates the *whiG* Overexpression PhenotypeScanning electron micrographs of the *whiG* mutant carrying the empty vector and the *whiG* mutant overexpressing *whiH* + *whiI*. Strains were imaged after 4 days of growth on MYM medium.

σ^WhiG^ Activity Is Not Correlated with σ^WhiG^ Protein Levels {#sec2.3}
--------------------------------------------------------------

To compare σ^WhiG^ protein levels and σ^WhiG^ activity during differentiation, we made protein and RNA extracts from the same WT developmental time course. Western blotting revealed that σ^WhiG^ was present at all developmental phases, with levels remaining constant to 15 h post-inoculation and only increasing about 2-fold across the life cycle ([Figures 4](#fig4){ref-type="fig"}A and 4B). In contrast, *whiI* mRNA levels, used as a proxy for σ^WhiG^ activity, increased almost 15-fold between 10 and 15 h ([Figure 4](#fig4){ref-type="fig"}C). The disparity between σ^WhiG^ protein levels and *whiI* transcript levels suggested that σ^WhiG^ might be subject to post-translational control that prevents activation of its target promoters at certain times during development.Figure 4σ^WhiG^ Activity Is Regulated Post-translationally by a Novel Anti-σ, RsiG(A) Automated western blot analysis showing σ^WhiG^ protein levels throughout development in Difco Nutrient Broth (DNB) medium, generated using the quantitative Wes capillary electrophoresis and blotting system (ProteinSimple, San Jose, CA; [STAR Methods](#sec4){ref-type="sec"}). Equal amounts (2.5 μg) of total protein were loaded for each sample, and σ^WhiG^ was detected with a polyclonal anti-σ^WhiG^ antibody. A single replicate is shown for each strain.(B) Quantification of σ^WhiG^ levels (area under each peak, a.u.). All samples were analyzed in triplicate, and the mean value and its SE are shown for each sample.(C) *whiI* mRNA abundance in the WT during submerged sporulation, determined by qRT-PCR. Expression values are calculated relative to the *hrdB* reference, normalized to the value at 10 h. RNA samples were prepared from the same culture as the protein samples analyzed in (A) and (B). All samples were analyzed in triplicate, and the mean value and its SE are shown for each sample.(D) *whiI* mRNA abundance during submerged sporulation in the *rsiG* mutant, determined by qRT-PCR. Expression values are calculated relative to the *hrdB* reference, normalized to the WT value at 10 h. The data for the WT are replotted from (C). All samples were analyzed in triplicate, and the mean value and its SE are shown for each sample.(E) Bacterial two-hybrid analysis to investigate the interaction between σ^WhiG^ and RsiG. The listed pairs of constructs were transferred into the BACTH reporter strain *E. coli* BTH101 by transformation. The resulting transformants were selected on L Broth agar containing 100 μg/mL carbenicillin and 50 μg/mL kanamycin and incubated at 37°C before single colonies were picked and subjected to β-galactosidase assays. Strains expressing fusions of both adenylate cyclase domains to the leucine zipper domain of GCN4 (zip) served as a positive control, whereas strains expressing fusions of one adenylate cyclase domain to a zip domain and the other to either WhiG or RsiG served as negative controls. Results are the average of three replicate cultures derived from the same single colony. Error bars represent SEM.(F) Co-expression and purification of a soluble σ^WhiG^-RsiG complex. σ^WhiG^ and RsiG were co-overexpressed in *E. coli* using pCOLADuet-1, with σ^WhiG^ carrying an N-terminal His tag. Following co-overexpression, the soluble extract was passed over a nickel column, and, after washing, bound proteins were eluted and analyzed on a 12% SDS-polyacrylamide gel.(G) Deletion of *rsiG* leads to hypersporulation on solid medium. Shown is a scanning electron micrograph of the *rsiG* mutant imaged after 7 days of growth on Difco Nutrient Agar (DNA) medium.See also [Figure S1](#mmc1){ref-type="supplementary-material"} and [Video S3](#mmc4){ref-type="supplementary-material"} for the effect of deleting *rsiG* on sporulation in liquid culture.

A likely means for the post-translational control of a σ factor would be sequestration from RNA polymerase (RNAP) by an anti-σ factor. Anti-σ factors are typically encoded next to their cognate σ factors, but no proteins homologous to known anti-σ factors are encoded within 50 kb of *whiG*. Although it has diverged functionally, σ^WhiG^ belongs to the flagellar clade of σ factors, and in motile bacteria, the flagellar σ is inhibited by the anti-σ factor FlgM ([@bib49], [@bib48], [@bib40], [@bib97], [@bib47], [@bib12]). However, no FlgM homolog is encoded in the *S. venezuelae* genome. Thus, for these reasons, we were unable to identify a candidate σ^WhiG^ anti-σ factor by bioinformatic means.

RsiG Is a σ^WhiG^ Cognate Anti-σ Factor Regulating the Progression of Multicellular Differentiation {#sec2.4}
---------------------------------------------------------------------------------------------------

To search for a candidate anti-σ factor, we screened a bacterial adenylate cyclase two-hybrid (BACTH) shotgun *S. venezuelae* genomic library using *whiG* as bait. Of 30 sequenced positive clones, ten were found to carry in-frame fusions to the same gene, *vnz19430*. Subsequently, we tested full-length Vnz19430 against full-length σ^WhiG^ in the BACTH system and found strong interaction ([Figure 4](#fig4){ref-type="fig"}E). *vnz19430* encodes a soluble, 24-kDa protein of previously unknown biochemical function. This gene was originally identified as a locus affecting morphological differentiation in the streptomycin producer *Streptomyces griseus* ([@bib56], [@bib109]), where it was named *amfC*, but no specific role in development was established. Based on the work described below, we renamed this gene *rsiG* (regulator of sigma WhiG). RsiG is unrelated to any previously identified anti-σ factor and is encoded ∼1.5 Mbp away from the *whiG* gene on the *S. venezuelae* chromosome.

To assess whether RsiG and σ^WhiG^ form a direct complex, we co-overexpressed the two proteins in *E. coli*, with σ^WhiG^ carrying an N-terminal His tag. When *S. venezuelae* σ^WhiG^ was expressed by itself, much of the protein was found in inclusion bodies. However, when RsiG and σ^WhiG^ were coexpressed, σ^WhiG^ was soluble. Further, RsiG co-purified with His-tagged σ^WhiG^ on a nickel column in approximately stoichiometric amounts, showing that RsiG and σ^WhiG^ form a direct complex ([Figure 4](#fig4){ref-type="fig"}F).

To confirm that RsiG regulates σ^WhiG^ activity *in vivo*, we next examined the phenotype associated with *rsiG* deletion. In striking similarity to the σ^WhiG^ overexpression phenotype, deletion of *ΔrsiG* caused a hypersporulation phenotype in which the vegetative hyphae differentiated into spore chains, again resulting in mature colonies with a biomass that consisted almost entirely of spores ([Figure 4](#fig4){ref-type="fig"}G). Because *S. venezuelae* can complete its life cycle in liquid culture ([@bib88], [@bib89]), we also examined developmental phenotypes in a microfluidic device using time-lapse fluorescence microscopy. Strains expressing an FtsZ-YPet fusion were introduced into the microfluidic system, and images were taken every 20 min to track development. In WT *S. venezuelae*, there was a period of vegetative growth during which the appearance of sporadic vegetative cross-walls could be seen. This was followed by a sporulation phase, in which less than half of the hyphae formed spore chains ([Figure S1](#mmc1){ref-type="supplementary-material"}; [Video S1](#mmc2){ref-type="supplementary-material"}). In contrast, when σ^WhiG^ was overexpressed, we observed a period of vegetative growth of similar length as that seen in the WT, but the subsequent sporulation phase was associated with a much more dramatic increase in the FtsZ-YPet signal, and the entire hyphal biomass was seen to sporulate ([Figure S1](#mmc1){ref-type="supplementary-material"}; [Video S2](#mmc3){ref-type="supplementary-material"}). The *ΔrsiG* mutant showed a similar phenotype as the σ^WhiG^ overexpression strain, but hypersporulation was less dramatic ([Figure S1](#mmc1){ref-type="supplementary-material"}; [Video S3](#mmc4){ref-type="supplementary-material"}).

Video S1. Time-Lapse Microscopy of the Wild-Type Strain Carrying the FtsZ-YPet Fusion and the Empty Vector, Related to Figure 1DIC and YFP channel videos are at 4 frames per second. The time following inoculation is indicated at the top left. Images were taken every 20 min. Videos were assembled in the Fiji software package (<http://fiji.sc/>). Scale bar, 5 μm.

Video S2. Time-Lapse Microscopy of the Wild-Type Strain Carrying the FtsZ-YPet Fusion and Overexpressing σ^WhiG^, Related to Figure 1DIC and YFP channel videos are at 4 frames per second. The time following inoculation is indicated at the top left. Images were taken every 20 min. Videos were assembled in the Fiji software package (<http://fiji.sc/>). Scale bar, 5 μm.

Video S3. Time-Lapse Microscopy of the *rsiG* Mutant Carrying the FtsZ-YPet Fusion, Related to Figure 4DIC and YFP channel videos are at 4 frames per second. The time following inoculation is indicated at the top left. Images were taken every 20 min. Videos were assembled in the Fiji software package (<http://fiji.sc/>). Scale bar, 5 μm.

Next we examined *whiI* mRNA levels, used as a proxy for σ^WhiG^ activity, in a developmental time course of the *rsiG* null mutant. Deletion of *rsiG* causes a dramatic increase in *whiI* transcription ([Figure 4](#fig4){ref-type="fig"}D). Thus, the hypersporulation phenotype of the *rsiG* mutant correlates with greatly increased expression of a σ^WhiG^ target gene. Each of the above phenotypes is consistent with RsiG acting as a σ^WhiG^-specific anti-σ *in vivo*.

Crystal Structures Reveal c-di-GMP-Mediated RsiG-σ^WhiG^ Complex Formation {#sec2.5}
--------------------------------------------------------------------------

Because RsiG shows no homology to any known anti-σ factor, it was unclear how it might bind and affect the function of σ^WhiG^. Thus, to address this question, we determined crystal structures of the complex. Two crystal forms were obtained ([Table S1](#mmc1){ref-type="supplementary-material"}). The structure of crystal form 1 was solved by selenomethionine single-wavelength anomalous diffraction (SAD) and refined to R~work~/R~free~ values of 19.5%/23.8% to 2.08-Å resolution ([Figure 5](#fig5){ref-type="fig"}A). This structure was then used to determine the structure of crystal form 2, which was refined to final R~work~/R~free~ values of 20.9%/27.9% to 3.00-Å resolution. Both structures reveal a 1:1 RsiG:σ^WhiG^ complex, with crystal form 1 having one RsiG-σ^WhiG^ complex in the crystallographic asymmetric unit (ASU) and crystal form 2 having three complexes in the ASU. The four complex structures are essentially identical and can be superimposed with root-mean-square deviations (RMSDs) of 0.64--0.75 Å for the corresponding Cα atoms of the complex ([Figure S2](#mmc1){ref-type="supplementary-material"}). Strikingly, each RsiG-σ^WhiG^ structure revealed the presence of a c-di-GMP dimer located at the σ^WhiG^-RsiG interface ([Figures 5](#fig5){ref-type="fig"}A and 5B; [Video S4](#mmc5){ref-type="supplementary-material"}). The c-di-GMP molecules appear to be key for complex formation by linking the proteins. Because no c-di-GMP was added prior to crystallization, the c-di-GMP molecules must have copurified with the complex from the *E. coli* expression system.Figure 5Structure of the *S. venezuelae* RsiG-σ^WhiG^ Complex(A) Ribbon diagram of the overall structure of the RsiG-σ^WhiG^ complex. RsiG is colored magenta. The σ regions of σ^WhiG^ are colored green, brown, and pale green for the σ~2~, σ~3~ and σ~4~ domains, respectively. The linker between σ~3~ and σ~4~ is colored wheat. The c-di-GMP dimer is shown as sticks. RsiG, σ^WhiG^, their secondary structural elements, and the σ regions of σ^WhiG^ are labeled.(B) Close-up of the c-di-GMP partially intercalated dimer with a Fo-Fc omit map included. The Fo-Fc map is shown as a blue mesh and contoured at 3.5 σ.(C) Selected c-di-GMP interactions with RsiG and σ^WhiG^. Note the two-fold symmetry evident in the interactions between the c-di-GMP dimer and the E(X)~3~S(X)~2~R(X)~3~Q(X)~3~D repeat motif found on each coiled-coil helix.(D) Superimposition of RsiG coiled coils. One E(X)~3~S(X)~2~R(X)~3~Q(X)~3~D repeat motif (magenta) was overlaid onto the second repeat (yellow). The result is that the motif residues that contact the c-di-GMP molecules also superimpose identically. The consensus repeat motif, ExxxSxxRxxxQxxxD, is included below the structure superimposition.See also [Figure S2](#mmc1){ref-type="supplementary-material"} for superimposition of the two solved RsiG-σ^WhiG^ structures as well as [Figure S3](#mmc1){ref-type="supplementary-material"} for detailed interactions within the complex.

Video S4. Rotation of the Overall Structure of the RsiG-σ^WhiG^ Complex, Related to Figure 5

In the structure of the RsiG-σ^WhiG^ complex, σ^WhiG^ adopts a compact form ([Figure 5](#fig5){ref-type="fig"}A). σ^WhiG^ is a type 3 σ factor and, thus, contains three σ domains: σ~2~ (residues 24--120, green in [Figure 5](#fig5){ref-type="fig"}A), σ~3~ (residues 121--171, brown), a linker that connects σ~3~ to σ~4~ (residues 172--183, wheat), and σ~4~ (residues 216--275, pale green). σ^WhiG^ also harbors an extra N-terminal helix, α1, preceding the σ~2~ domain, which provides contacts to RsiG ([Figure 5](#fig5){ref-type="fig"}A). Structural homology (Dali) searches reveal that, as expected, each domain of σ^WhiG^ is structurally similar to the corresponding domains of other σ factors. Like other σ~2~ domains, the σ^WhiG^ σ~2~ domain core consists of three α helices (α2--α4), and the σ^WhiG^ σ~4~ domain consists of four α helices (α9--α12). Residues 184--215, which comprise part of the σ~3~-σ~4~ linker, are disordered in the σ^WhiG^ structures. Individual σ regions are flexibly linked and adopt multiple orientations when not in complex with RNAP or an anti-σ factor ([@bib31]). Thus, it was interesting that Dali searches revealed that σ^WhiG^ domains σ~2~ and σ~4~ superimpose well as a unit onto the same regions of the σ^28^ structure that was solved bound to its anti-σ factor, FlgM, despite their σ~3~ domains adopting distinct orientations ([@bib97]; [Figure S3](#mmc1){ref-type="supplementary-material"}A). In the σ^FliA^-FlgM complex, the σ~3~ region of σ^FliA^ has an elongated α3, and its compact structure is stabilized by a salt bridge between Glu145, located on α3 of σ~3~, and Arg115 from its σ~2~ domain. The conservation of these residues, combined with crosslinking data, led to the suggestion that this salt bridge may form in all related σ factors and stabilize the apo form ([@bib97], [@bib96]). Notably, these residues and the corresponding salt bridge are indeed conserved in σ^WhiG^, even though, as noted, the σ^WhiG^ σ~3~ domain does not have an elongated α3. In σ^WhiG^, the corresponding salt bridge is formed between Glu180 on α4 helix of σ~3~ and the conserved Arg82 on σ~2~ ([Figure S3](#mmc1){ref-type="supplementary-material"}A). These findings suggest that this interaction can be maintained in different structural contexts for related type 3 σ factors.

The majority of the contacts from the anti-σ factors FlgM ([@bib97]) and RsiG are to the σ~2~ and σ~4~ domains of their σ partner. However, the similar relative conformations of the σ~2~ and σ~4~ domains in σ^WhiG^ and σ^28^ do not reflect similar interactions with their anti-σ factors. RsiG makes distinct contacts with σ^WhiG^ and also has a fold that is entirely different from FlgM, consisting of 6 α helices. Indeed, the RsiG structure is distinct from any previously solved structure in the protein database; Dali searches failed to identify any structure similar to RsiG. A striking feature of the RsiG structure is the presence of an extended antiparallel coiled coil formed by helices α1 and α5 ([Figure 5](#fig5){ref-type="fig"}A). These two helices are connected to short helices (α2, α3, α4, and α6) that brace RsiG to the sides of σ^WhiG^. Helix α2 is connected to α3-α4 by a long, meandering loop (residues 104--125) that encircles the bound c-di-GMP ([Figure 5](#fig5){ref-type="fig"}A).

The RsiG-σ^WhiG^ Interaction Is Mediated by a Unique c-di-GMP Dimer {#sec2.6}
-------------------------------------------------------------------

σ^WhiG^ is a key regulator of the late stage of *Streptomyces* development, differentiation of the reproductive hyphae into spores. The finding that c-di-GMP mediates RsiG-σ^WhiG^ complex formation reveals c-di-GMP as the central integrator of *Streptomyces* development; we showed recently that the activity of the master repressor BldD, which controls the initial onset of *Streptomyces* development, is itself controlled by a c-di-GMP tetramer ([@bib105], [@bib92]). In the RsiG-σ^WhiG^ structure, c-di-GMP promotes the correct conformation of RsiG for σ^WhiG^ binding and locks the proteins together. The c-di-GMP dimer bound in the RsiG-σ^WhiG^ complex is also different from c-di-GMP dimers found in previously solved structures of DNA regulatory proteins or other physiologically established c-di-GMP complexes. Specifically, in previous structures of c-di-GMP dimers bound to regulators, the four guanine bases make classical stacking interactions to form intercalated dimers ([@bib55], [@bib70]; Schumacher et al., 2016; [@bib91], [@bib107], [@bib80]). In contrast, in the RsiG-σ^WhiG^-bound c-di-GMP dimer, only the two central bases are stacked, whereas both guanine bases at the edges of the dimer are rotated out of the stacking plane, placing them nearly perpendicular to the central bases ([Figures 5](#fig5){ref-type="fig"}B and 5C). Further, the c-di-GMP-bound dimer adopts a symmetrical structure because of the equivalence of contacts from the conserved residues of the coiled-coil repeat elements. Indeed, although the two helices of the coiled coil are not formed by dimerization of two separate subunits, each of the coiled-coil helices has an E(X)~3~S(X)~2~R(X)~3~Q(X)~3~D repeat (RsiG residues 64--79 \[repeat 1\] and residues 162--177 \[repeat 2\]), where the conserved E, S, R, Q, and D from each motif make identical contacts to the c-di-GMP molecules ([Figure 5](#fig5){ref-type="fig"}D; [Video S4](#mmc5){ref-type="supplementary-material"}). Remarkably, when repeat 1 from a RsiG-σ^WhiG^ complex is overlaid onto repeat 2, the other repeat elements also become overlaid, as do the c-di-GMP dimers ([Figure S3](#mmc1){ref-type="supplementary-material"}B; [Figure 5](#fig5){ref-type="fig"}D). Thus, the repeat motif is located in the same position on each helix of the coiled coil, which suggests that the helices may have arisen from an intragenic duplication event (see [Discussion](#sec3){ref-type="sec"}).

In the RsiG-σ^WhiG^ complex, each conserved residue of the E(X)~3~S(X)~2~R(X)~3~Q(X)~3~D repeat motif contacts a c-di-GMP molecule. The serines of the motif help position the conserved glutamic acid and arginine side chains to interact with the c-di-GMP molecules while also contacting the c-di-GMP phosphates. The glutamic acid side chains of residues Glu64 and Glu162 interact with ribose hydroxyl groups. The Q(X)~3~D motif is responsible for recognizing the rotated guanine bases at each end of the c-di-GMP dimer, and the aspartic acids Asp79 and Asp177 recognize the Watson Crick faces of these guanines, and the glutamines Gln75 and Gln173 stack against the rotated bases ([Figure 5](#fig5){ref-type="fig"}C; [Figure S3](#mmc1){ref-type="supplementary-material"}C). The conserved arginines from each motif, Arg71 and Arg169, read the stacked guanines located at the center of the c-di-GMP dimer by hydrogen bonding to the O6 and N7 atoms of the bases (the Hoogsteen face). Thus, the contacts from the conserved aspartic acids and arginines provide base specificity. The contacts from the RsiG coiled-coil helices also anchor the c-di-GMP dimer in place, positioning it to make interactions with multiple RsiG loop residues. Specifically, Asp106 and His110 make phosphate backbone contacts to c-di-GMP, His110 and Arg115 provide stacking interactions via their side chains, Ser108 contacts a guanine base, and Ser112 interacts with a c-di-GMP phosphate group ([Figure S3](#mmc1){ref-type="supplementary-material"}C). These interactions from the c-di-GMP dimer to the middle of the RsiG loop help anchor it against σ^WhiG^. Although most of the interactions with c-di-GMP in the complex are mediated by RsiG, σ^WhiG^ residues Lys57, Gly61, and Arg62 from α helix 2 of the σ^WhiG^ σ~2~ domain also interact with the c-di-GMP dimer ([Figure 5](#fig5){ref-type="fig"}C). σ^WhiG^ residue Gly61, which packs against one of the ribose groups of c-di-GMP, plays an important role in this interaction because of its small size; any side chain at this position of σ^WhiG^ would clash with the c-di-GMP. Notably, multiple sequence alignments show that the residues from RsiG and σ^WhiG^ that contact c-di-GMP are highly conserved among protein homologs, in particular the key c-di-GMP binding residues from the E(X)~3~S(X)~2~R(X)~3~Q(X)~3~D repeat motifs (see [Discussion](#sec3){ref-type="sec"}).

RsiG-c-di-GMP Interaction with σ^WhiG^ and Inhibition of σ^WhiG^ Sigma Function {#sec2.7}
-------------------------------------------------------------------------------

The bound c-di-GMP dimer ties RsiG and σ^WhiG^ together by mediating contacts to each protein and also by acting as a chaperone to enable folding of the RsiG loop around σ^WhiG^. This interaction results in burial of a sizeable 2,353 Å^2^ of the RsiG and σ^WhiG^ surface from solvent. The N-terminal helix and helices α2 and α3 of the σ^WhiG^ σ~2~ domain make extensive contacts to RsiG helices α2, α3, and α4. The C-terminal portion of the first helix of the RsiG coiled coil (residues 69--80) also contributes to this σ^WhiG^ binding surface. This contact region is primarily hydrophobic, with σ^WhiG^ residue Leu50 inserting into a RsiG hydrophobic pocket composed of residues Ile80, Val95, Leu99, and Leu143 and RsiG residue Val138 interfacing with σ^WhiG^ residues Pro26, Leu29, Leu32, and His51 ([Figure 6](#fig6){ref-type="fig"}A). In addition, there are stacking interactions between RsiG Tyr69 and σ^WhiG^ Tyr58 and a salt bridge between RsiG Asp142 and σ^WhiG^ Arg43 ([Figure 6](#fig6){ref-type="fig"}A). The RsiG loop that folds around the c-di-GMP molecules fills a gap between the σ~2~ and σ~4~ domains in the otherwise compact σ^WhiG^ structure, which helps brace σ~4~ against RsiG ([Figure 5](#fig5){ref-type="fig"}A). This loop region is also the only contact from RsiG to σ^WhiG^ σ~3~. Although the RsiG loop stabilizes σ~4~ in position, residues from the N-terminal and C-terminal ends of the RsiG coiled coil and the last RsiG helix, α6, present an extensive surface for contacting σ~4~ helices α9--α11. This interaction is also largely hydrophobic, with σ^WhiG^ residues Ile223, Thr232, Thr235, Leu236, Tyr239, and Leu242 interacting with RsiG residues Ile183, Tyr187, Leu197, and Leu198. Hydrogen bond or electrostatic interactions are also found between σ^WhiG^ residue Glu240 and RsiG residues Arg54, Arg57, Arg58, and Tyr187 ([Figure 6](#fig6){ref-type="fig"}B).Figure 6RsiG-σ^WhiG^ Complex Interactions and the Mechanism of σ^WhiG^ Inhibition by RsiG(A) Close-up of the interaction interface between RsiG (colored magenta) and the σ~2~ domain of σ^WhiG^ (colored green). Residues that make contacts are shown as sticks and are labeled.(B) Interaction interface of RsiG (colored magenta) and the σ~4~ domain of σ^WhiG^. As in (A), residues that make contacts are shown as sticks and are labeled.(C) Comparison of the structures of RsiG-bound σ^WhiG^ (left) and RNAP-bound σ (right). The σ~3~ regions of each σ factor (both colored green) are shown in the same orientation to allow direct comparison. The σ~2~ and σ~4~ domains are colored cyan and red, respectively, and RsiG is colored magenta. Note that the RsiG-bound σ^WhiG^ is compact in shape, in contrast to the extended RNAP-bound σ.(D) Overlay of the σ~2~ region of RsiG-bound σ^WhiG^ with the *E. coli* σ^E^~2~ bound to the −10 DNA element, showing that the DNA would clash with RsiG in the RsiG-σ^WhiG^ complex.(E) Overlay of the σ~4~ region of RsiG-bound σ^WhiG^ with the *E. coli* σ^E^~4~ complexed to the −35 DNA element. Here, the DNA would clash with the c-di-GMP molecules bound to the RsiG-σ^WhiG^ complex (circled).

σ factors play a key role in bacterial transcription, associating with RNAP to dictate the promoter specificity of the resulting holoenzyme. Promoter specificity is determined principally by the σ~2~ and σ~4~ domains, which bind to the −10 and −35 regions of the promoter, respectively ([@bib31]). When σ factors bind RNAP, they form a highly extended structure that is exposed for promoter contact ([Figure 6](#fig6){ref-type="fig"}C). Most of the structures available for anti-σ-σ complexes have been determined for the smaller extracytoplasmic function (ECF) or group IV σ factors, which contain only domains σ~2~ and σ~4~ ([@bib48], [@bib13], [@bib75]). Structures of σ factors bound to ECF anti-σ factors have revealed that most of these anti-σ factors contact both the σ~2~ and σ~4~ regions ([@bib13], [@bib93]), whereas structures of anti-σ factors complexed with larger σ factors often only contact one σ factor domain ([@bib14], [@bib57], [@bib77], [@bib108]). Indeed, aside from the RsiG-σ^WhiG^ complex, the only other non-ECF anti-σ-σ complex revealing binding of multiple σ domains by the anti-σ is the *Aquifex aeolicus* FliA-FlgM complex ([@bib97]). Analysis of the RsiG-σ^WhiG^ structure reveals that RsiG binding inactivates the sigma function of σ^WhiG^ in multiple ways. First, when bound to RsiG, σ^WhiG^ adopts a highly compact structure where the σ~2~ and σ~4~ domains are separated by ∼25 Å (measured from center to center) compared with ∼70 Å when bound to RNAP ([Figure 6](#fig6){ref-type="fig"}C). Second, superimposition of σ~2~ and σ~4~ of σ^WhiG^ onto *E. coli* σ^E^~2~ bound to its −10 element and *E. coli* σ^E^~4~ bound to its −35 element, respectively, reveals multiple points of clash with the promoter DNA ([Figures 6](#fig6){ref-type="fig"}D and 6E). Thus, these analyses show that the RsiG-bound σ^WhiG^ would be unable to form an active holoenzyme with RNAP.

c-di-GMP Controls RsiG-σ^WhiG^ Complex Formation {#sec2.8}
------------------------------------------------

The structure of the RsiG-(c-di-GMP)~2~-σ^WhiG^ complex suggested that RsiG would likely be able bind c-di-GMP in the absence of σ^WhiG^. To test this hypothesis and to quantify any interaction, we performed fluorescence polarization (FP)-based binding experiments. These studies were carried out with the fluoresceinated probe 2′-Fluo-AHC-c-di-GMP. This probe harbors a fluorescein dye on one ribose, which, our structures revealed, would not block binding to RsiG. The FP experiments showed that RsiG alone binds 2′-Fluo-AHC-c-di-GMP with a K~d~ of 6.5 ± 1.5 μM ([Figure 7](#fig7){ref-type="fig"}A). RsiG showed no binding to the identically fluoresceinated c-di-AMP derivative 2′-Fluo-AHC-c-di-AMP ([Figure 7](#fig7){ref-type="fig"}A). We next examined binding of c-di-GMP to RsiG-σ^WhiG^. These analyses resulted in a K~d~ of 0.39 ± 0.05 μM ([Figure S4](#mmc1){ref-type="supplementary-material"}A), indicating that the complex binds c-di-GMP with much higher affinity than RsiG alone. This is consistent with the finding that, although RsiG provides most of the contacts to c-di-GMP, σ^WhiG^ also contacts c-di-GMP, but, more importantly, σ^WhiG^ appears to aid in folding or stabilizing the correct conformation of RsiG required for c-di-GMP binding.Figure 7Creation of an RsiG Derivative Defective in c-di-GMP Binding (RsiG^∗^) and Demonstration that c-di-GMP Binding Is Required for RsiG Activity *In Vivo*(A) Fluorescence polarization (FP)-based binding isotherms of WT RsiG binding to 2′-Fluo-AHC-c-di-GMP (red circles), WT RsiG binding to 2′-Fluo-AHC-c-di-AMP (blue squares), RsiG^∗^ binding to 2′-Fluo-AHC-c-di-GMP (green diamonds), and RsiG^∗^ binding to 2′-Fluo-AHC-c-di-AMP (black crosses). Each binding curve is a representative from 3 technical replicates. The y axis shows millipolarization units (mP), and the x axis shows the concentration of RsiG protein (micromolar).(B) Scanning electron micrographs showing that deletion of *rsiG* causes hypersporulation and that the *rsiG* mutant can be complemented with WT *rsiG* but that it cannot be complemented with the *rsiG^∗^* allele (R71A, D79A, R169A, D177A) encoding a protein defective in c-di-GMP binding. Strains were imaged after 7 days of growth on DNA medium.(C) RsiG^∗^ is not affected regarding protein stability. Shown is an automated western blot analysis comparing RsiG protein levels in the *rsiG* mutant complemented with the WT *rsiG* allele and the *rsiG^∗^* allele, generated using the quantitative Wes capillary electrophoresis and blotting system (ProteinSimple, San Jose, CA; [STAR Methods](#sec4){ref-type="sec"}). Equal amounts (2.5 μg) of total protein were loaded for each sample, and RsiG was detected with a polyclonal anti-RsiG antibody. A single replicate is shown for each strain. Strains were grown in DNB, and samples were collected at 15 h.(D) Quantification of RsiG levels (area under each peak, a.u.).All samples were analyzed in triplicate, and the mean value and its SE are shown for each sample. See also [Figure S4](#mmc1){ref-type="supplementary-material"} for biochemical analysis of the dependence of complex formation on c-di-GMP as well as [Figure S5](#mmc1){ref-type="supplementary-material"} for conservation of c-di-GMP-binding residues among homologs of RsiG and σ^WhiG^.

The ability of RsiG to discriminate between c-di-GMP and c-di-AMP was consistent with the crystal structure, which showed that the arginine and aspartic acid residues in the two E(X)~3~S(X)~2~R(X)~3~Q(X)~3~D motifs make base-specifying contacts to the guanines of the c-di-GMP dimer. To disrupt c-di-GMP binding by RsiG, we substituted the arginine and aspartic acid residues in both E(X)~3~S(X)~2~R(X)~3~Q(X)~3~D motifs with alanines to create RsiG^∗^ (R71A, D79A, R169A, D177A). RsiG^∗^ failed to bind 2′-Fluo-AHC-c-di-GMP in FP assays and also, as expected, did not bind 2′-Fluo-AHC-c-di-AMP ([Figure 7](#fig7){ref-type="fig"}A). Overall, these data demonstrate unequivocally that anti-σ alone binds specifically to c-di-GMP but not to c-di-AMP and that the base-specifying arginine and aspartic acid residues of the E(X)~3~S(X)~2~R(X)~3~Q(X)~3~D motif are essential for this interaction.

To determine whether c-di-GMP binding to RsiG is required for the anti-σ to sequester σ^WhiG^, we coexpressed σ^WhiG^ and His~6~-RsiG^∗^. Although σ^WhiG^ copurified with WT His~6~-RsiG, σ^WhiG^ did not copurify with His~6~-RsiG^∗^ ([Figure S4](#mmc1){ref-type="supplementary-material"}B). Further, we built a complementation construct expressing a protein solely defective in c-di-GMP binding (RsiG^∗^) and found that it had no ability to complement an *S. venezuelae rsiG* mutant, in contrast to an otherwise identical construct expressing WT RsiG, which restored normal development ([Figures 7](#fig7){ref-type="fig"}B--7D). These data show that c-di-GMP mediates the ability of RsiG to restrain σ^WhiG^ activity *in vitro* and *in vivo*.

Discussion {#sec3}
==========

This work is the first to describe that c-di-GMP targets a σ factor and its functionality. As a result of this discovery, it is now clear that c-di-GMP signals through BldD and σ^WhiG^, respectively, to control the two most dramatic transitions of the *Streptomyces* life cycle: the formation of reproductive aerial hyphae and their differentiation into spore chains. In both cases, c-di-GMP functions as a "brake." In the first case, BldD sits at the top of the developmental regulatory network, serving to repress a large set of genes, including many genes of the core transcriptional regulatory cascade itself. The ability of BldD to repress this suite of sporulation genes is dependent on binding to a tetrameric cage of c-di-GMP that acts as an inter-subunit linker, enabling BldD to dimerize and, hence, bind DNA ([@bib105], [@bib92], [@bib10]). Thus, by signaling through the BldD~2~-(c-di-GMP)~4~ complex, c-di-GMP functions to prolong vegetative growth and prevent initiation of development. σ^WhiG^ acts later in the development pathway, after the formation of aerial hyphae, controlling the differentiation of these reproductive structures into spores. By driving σ^WhiG^ into an inactive RsiG-(c-di-GMP)~2~-σ^WhiG^ complex, c-di-GMP acts to block this developmental transition. The difference between these two signaling events can be seen in the phenotypes associated with deletion of *bldD* or *rsiG* in *S. venezuelae*. When *rsiG* is deleted, the duration of vegetative growth seen in time-lapse imaging is the same as in the WT, but the subsequent sporulation phase is much more pronounced than in the WT ([Figure S1](#mmc1){ref-type="supplementary-material"}; [Videos S1](#mmc2){ref-type="supplementary-material"} and [S3](#mmc4){ref-type="supplementary-material"}). In contrast, deletion of *bldD* results in a short period of vegetative growth and precocious sporulation ([@bib105]).

Global c-di-GMP levels fall sharply as *S. venezuelae* enters development (A. Latoscha and N. Tschowri, personal communication), and BldD dissociates from DNA before σ^WhiG^ is released from RsiG. The most parsimonious explanation for this order of events is the K~d~ values of the proteins for c-di-GMP. BldD binds 2′-Fluo-AHC-c-di-GMP with a K~d~ of 2.5 ± 0.6 μM ([@bib105]), whereas the K~d~ for \[RsiG + σ^WhiG^\] is 0.39 ± 0.05 μM, meaning that, as c-di-GMP levels drop, BldD would become inactive before σ^WhiG^ is released from RsiG. A more complex issue is how c-di-GMP levels are controlled. In *S. venezuelae*, there are 11 enzymes involved in c-di-GMP metabolism ([@bib104], [@bib4], [@bib58]). Five of these are composite GGDEF-EAL proteins carrying both the synthetic and degradative domains, in most cases in combination with multiple regulatory domains (e.g., PAS GAF, PAC) that are likely to determine which activity is dominant, depending on regulatory inputs ([@bib104], [@bib4], [@bib58]). Further, four of these genes (*cdgA*, *cdgB*, *cdgC*, and *cdgE)* are direct regulatory targets of BldD, creating numerous potential feedback loops ([@bib104], [@bib4], [@bib58]). Thus, determining how *Streptomyces* controls c-di-GMP levels in time and space will be a major challenge in the future.

Like *whiG*, *rsiG* is present in more than 98% of the 802 complete and annotated *Streptomyces* genomes available at GenBank, suggesting that RsiG is likely to play a conserved function throughout the genus. In addition, RsiG can also be found outside of the Streptomycetes. In a search of 3,962 reference/representative bacterial genomes available at GenBank (60 of which are *Streptomyces* genomes), we found a total of 134 *rsiG* homologs, all exclusively in members of the phylum Actinobacteria ([Table S2](#mmc1){ref-type="supplementary-material"}). Outside of the genus *Streptomyces,* most *rsiG* homologs are found in members of the families Geodermatophilaceae and Pseudonocardiaceae.

All 134 genomes with an *rsiG* homolog also have a *whiG* homolog, suggesting that *whiG* always co-occurs with *rsiG*. Sequence logos derived from amino acid sequence alignments of RsiG and σ^WhiG^ homologs show that the residues that bind the cyclic dinucleotide in our structure are strikingly well conserved. Specifically, in RsiG, the two α helices involved in c-di-GMP binding both contain well-conserved E(X)~3~S(X)~2~R(X)~3~Q(X)~3~D motifs ([Figure S5](#mmc1){ref-type="supplementary-material"}A). The only exception occurs in the first of the two helices, where Gln75 in the *S. venezuelae* protein is frequently replaced with a histidine among RsiG homologs. Glutamine and histidine, however, are both highly suitable to make the stacking interaction with the guanine base of c-di-GMP seen in the *S. venezuelae* structure. The striking repetition of the E(X)~3~S(X)~2~R(X)~3~\[Q/H\](X)~3~D motif in RsiG and the 33% overall sequence identity between the two α helices raises the possibility that they have arisen from an ancestral intragenic duplication event. The two residues of σ^WhiG^ that make direct contacts to c-di-GMP, Lys57 and Arg62, both of which are found in σ region 2.1, are also highly conserved among σ^WhiG^ homologs that co-occur with RsiG ([Figure S5](#mmc1){ref-type="supplementary-material"}B). In addition, the glycine residue found at position 61 in *S. venezuelae* σ^WhiG^ is likely to be important for c-di-GMP binding because a larger side chain at that position would cause a steric clash. Consistent with this conclusion, Gly61 is not well conserved in the true flagellar σ factors from organisms that do not possess an *rsiG* homolog, such as *E. coli* σ^28^ and *B. subtilis* SigD ([@bib97]), but this residue is highly conserved among the true σ^WhiG^ proteins that co-occur with RsiG ([Figure S5](#mmc1){ref-type="supplementary-material"}B). The RsiG-σ^WhiG^ interface is complex and not as clearly defined as the residues required for c-di-GMP binding. However, many of the additional highly conserved residues we observed among σ^WhiG^ and RsiG homologs are involved in the interface between the two proteins ([Figures S5](#mmc1){ref-type="supplementary-material"}A and S5B). Finally, all the Actinobacteria that encode a homolog of RsiG also encode DGCs, implying the presence of c-di-GMP. These combined observations suggest that this second messenger controls RsiG-σ^WhiG^ complex formation across the *Streptomyces* genus and beyond.

STAR★Methods {#sec4}
============

Key Resources Table {#sec5.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Antibodies**Rabbit polyclonal anti-σ^WhiG^Cambridge Research BiochemicalsCustom madeRabbit polyclonal anti-RsiGCambridge Research BiochemicalsCustom made**Bacterial and Virus Strains**Please refer to [Table S3](#mmc1){ref-type="supplementary-material"}N/A**Chemicals, Peptides, and Recombinant Proteins**OCT CompoundAgar Scientific LtdCat\#AGR1180cOmplete, Mini, EDTA-free Protease Inhibitor CocktailRoche Applied ScienceCat\#11836170001Protein A--SepharoseSigmaCat\#P3391Cobalt resinTakara Bio USACat\#635504Proteinase KRocheCat\#RPROTK-ROTRIzolInvitrogenCat\#15596026GeneChip arrayAffymetrix*Streptomyces* diS_div712aSuperScript II reverse transcriptaseInvitrogenCat\#18064-014Random PrimersInvitrogenCat\#48190011Bradford ReagentBioradCat\#500-00062′- O- (6- \[DY-505-05\]- aminohexylcarbamoyl))guanosine- 3′, 5′- cyclic monophosphate (2′-\[DY505-05\]-AHC-cGMP)BioLogCat\#D135-0012′- O- (6- \[DY-505-05\]- aminohexylcarbamoyl))guanosine- 3′, 5′- cyclic monophosphate (2′-\[DY505-05\]-AHC-cAMP), sodium saltBioLogCat\#C195-001**Critical Commercial Assays**QIAquick PCR Purification KitQIAGENCat\#28104RNeasy Mini KitQIAGENCat\#74104TURBO DNA-*free* KitAmbionCat\#AM1907SensiFAST SYBR No-ROX kitBiolineCat\#BIO-98005Anti-Rabbit Detection Module for Jess, Wes, Peggy Sue or Sally SueProteinSimpleCat\#DM-00112-230 kDa Jess or Wes Separation Module, 8 × 25 capillary cartridgesProteinSimpleCat\#SM-W004**Deposited Data**Crystal StructuresThis paperPDB: 6PFJ and PDB: 6PFVChIP-seq dataThis paperE-MTAB-8160 (ArrayExpress)Microarray transcriptional profiling dataThis paperE-MTAB-8114 (ArrayExpress)**Oligonucleotides**Please refer to [Table S3](#mmc1){ref-type="supplementary-material"}N/A**Recombinant DNA**Please refer to [Table S3](#mmc1){ref-type="supplementary-material"}N/A**Software and Algorithms**Fijiopen-source software package<http://fiji.sc/>PrismGraphpad<https://www.graphpad.com/scientific-software/prism/>

Lead Contact and Materials Availablity {#sec5.2}
--------------------------------------

The Lead Contact is Mark Buttner (<mark.buttner@jic.ac.uk>). All stable reagents generated in this study are available from the Lead Contact with a completed Materials Transfer Agreement.

Experimental Model and Subject Details {#sec5.3}
--------------------------------------

For details about the bacterial strains and culture conditions, please refer to the strain list ([Table S3](#mmc1){ref-type="supplementary-material"}) and [Method Details](#sec5.4){ref-type="sec"}.

Method Details {#sec5.4}
--------------

### Bacterial strains, plasmids, media, and conjugations {#sec5.4.1}

Strains, plasmids, and oligonucleotides used in this study are listed in [Table S3](#mmc1){ref-type="supplementary-material"}. *Escherichia coli* strain DH5α was used for plasmid and cosmid propagation. Disruption cosmids were generated using *E. coli* strain BW25113 ([@bib23]) carrying a λ RED plasmid, pIJ790. The *dam dsm hsdS E. coli* strain ET12576 containing pUZ8002 ([@bib76]) was used to conjugate cosmids and plasmids into *S. venezuelae* ([@bib54], [@bib8]). *E. coli* strains were grown on LB or LB agar at 37°C. *S. venezuelae* strains were typically grown in liquid or solid MYM media supplemented with trace element solution ([@bib8]) but the hypersporulation phenotype was examined on Difco Nutrient Agar (DNA) or in Difco Nutrient Broth (DNB), where this phenotype is strongest. Where required for selection, the following antibiotics were added to growth media: 50 μg/mL apramycin, 100 μg/mL carbenicillin, 25 μg/mL chloramphenicol, 25 μg/mL hygromycin, and/or 50 μg/mL kanamycin.

### Construction and complementation of S. venezuelae null mutants {#sec5.4.2}

The *whiG*, *vnz15005*, and *rsiG* null mutants were generated using the Redirect PCR targeting system ([@bib37], [@bib38]). A cosmid library that covers \> 98% of the *S. venezuelae* genome has been constructed and is fully documented at <http://strepdb.streptomyces.org.uk/>. Cosmid Sv-6_E12 (contains *whiG*), Pl2_H19 (contains *vnz15005*), or Sv-2_C01 (contains *rsiG*) was introduced to *E. coli* strain BW25113 containing pIJ790 and *whiG*, *vnz15005*, or *rsiG* was replaced with the *apr-oriT* cassette amplified from pIJ773 using primer pairs vnz26215_redi_F and vnz26215_redi_R, vnz15005_redi_F and vnz15005_redi_R, or vnz19430_redi_F and vnz19430_redi_R. Null mutants were confirmed by PCR analysis using the flanking primer sets vnz26215_check_F and vnz26215_check_R, vnz15005_check_F and vnz15005_check_R, or vnz19430_check_F and vnz19430_check_R. Complementation of the *whiG* and *rsiG* null mutants was achieved by amplifying the coding region and native promoter of each gene using the primer sets vnz26215_comp_F and vnz26215_comp_R, or vnz19430_comp_F and vnz19430_comp_R and cloning each fragment into HindIII/Asp718-cut pIJ10770 ([@bib89]) to generate plasmids pIJ10900 and pIJ10901. Complementation of the *rsiG* null mutant with the *rsiG^∗^* allele was accomplished by gene synthesis of *rsiG^∗^* (GenScript), with identical promoter and coding sequence to that found in pIJ10901 except for the four mutated codons. The *rsiG^∗^* allele was subsequently cloned into HindIII/Asp718-cut pIJ10770 to generate pIJ10913. Complementation plasmids were introduced into *S. venezuelae* null mutants by conjugation.

### Overexpression of proteins in S. venezuelae {#sec5.4.3}

The coding region of *whiG* was amplified using primer set vnz26215_ermE_F and vnz26215_ermE_R. The PCR product was cloned into NdeI/HindIII-cut pIJ10257 ([@bib45]) to generate plasmid pIJ10902. This construction results in *whiG* being placed under the control of the strong constitutive *ermE^∗^* promoter.

For overexpression of both WhiH and WhiI together, the coding regions of both genes were amplified with primers HI_ermE_P1and HI_ermE_P2 (for *whiH*) HI_ermE_P3 and HI_ermE_P4 (for *whiI)*. Both genes, separated by a short spacer containing a ribosome binding site, were then inserted into NdeI/HindIII-digested pIJ10257 by Gibson Assembly ([@bib36]). This resulted in the creation of plasmid pIJ10906, which contains *whiH* and *whiI* under the control of the same *ermE^∗^* promoter. All overexpression plasmids were introduced into WT *S. venezuelae* or the *ΔwhiG* mutant by conjugation.

### Scanning Electron Microscopy {#sec5.4.4}

Colonies were mounted on the surface of an aluminum stub with optimal cutting temperature compound (Agar Scientific Ltd, Essex, UK), plunged into liquid nitrogen slush at approximately −210°C to cryopreserve the material, and transferred to the cryostage of an Alto 2500 cryotransfer system (Gatan, Oxford, England) attached to a FEI NanoSEM 450 field emission gun scanning electron microscope (FEI Ltd, Eindhoven, the Netherlands). The surface frost was sublimated at −95°C for 3½ min before the sample was sputter coated with platinum for 2 min at 10 mA at below −110°C. Finally, the sample was moved onto the cryostage in the main chamber of the microscope, held at approximately −130°C, and viewed at 3 kV.

### Chromatin immunoprecipitation, library construction, sequencing, and ChIP-seq data analysis {#sec5.4.5}

WT *S. venezuelae* and the *ΔwhiG* null mutant (negative control) were grown in 30 mL volumes of MYM. During mid-sporulation, formaldehyde was added to cultures at a final concentration of 1% (v/v) and incubation was continued for 30 min. Glycine was then added to a final concentration of 125 mM to stop the cross-linking. Cultures were left at room temperature (RT) for 5 min before the mycelium was harvested and washed twice in PBS buffer (pH 7.4). Each mycelial pellet was resuspended in 0.75 mL lysis buffer (10 mM Tris HCl pH 8.0, 50 mM NaCl) containing 10 mg/mL lysozyme and protease inhibitor (Roche Applied Science) and incubated at 37°C for 25 min. An equal volume of IP buffer (100 mM Tris HCl pH 8, 250 mM NaCl, 0.5% Triton X-100, 0.1% SDS) containing protease inhibitor was added and samples were chilled on ice. Samples were sonicated for 8 cycles of 20 s each at 8 microns to shear the chromosomal DNA into fragments ranging from 300-1000 bp in size. Samples were centrifuged twice at 13,000 rpm at 4°C for 10 min to clear the cell extract. The supernatant was incubated with 10% (v/v) protein A-Sepharose (Sigma) for 1 h on a rotating wheel to remove non-specifically binding proteins. Samples were then centrifuged for 15 min at 4°C and 13,000 rpm to remove the beads. Supernatants were incubated with 10% (v/v) anti-σ^WhiG^ polyclonal antibody overnight at 4°C with rotation. Subsequently, 10% (v/v) protein A-Sepharose was added to precipitate σ^WhiG^ and incubation was continued for 4 hr. Samples were centrifuged at 4°C and 3500 rpm for 5 min and the pellets were washed twice with 0.5x IP buffer, and then twice with 1x IP buffer. Each pellet was incubated overnight at 65°C in 150 μl IP elution buffer (50 mM Tris HCl pH 7.6, 10 mM EDTA, 1% SDS) to reverse cross-links. Samples were centrifuged at 13,000 rpm for 5 min to remove the beads. Each pellet was re-extracted with 50 μl TE buffer (10 mM Tris HCl pH 7.4, 1 mM EDTA) and the supernatant incubated with 0.2 mg/mL Proteinase K (Roche) for 2 h at 55°C. The resulting samples were extracted with phenol-chloroform and further purified using QiaQuick columns, eluting in 50 μL EB buffer (QIAGEN). Library construction and sequencing were performed by the Earlham Institute, Norwich Research Park, Norwich, United Kingdom.

The reads in the fastq files received from the sequencing contractor were aligned to the *S. venezuelae* genome (GenBank: [CP018074](ncbi-n:CP018074){#intref0050}) using the bowtie2 software (version 2.2.9), which resulted in one SAM (.sam) file for each fastq file (single ended sequencing). For each sam file, the *depth* command of *samtools* (version 1.8) was used to arrive at the depth of sequencing at each nucleotide position of the *S. venezuelae* chromosome (<https://www.sanger.ac.uk/science/tools/samtools-bcftools-htslib>). From the sequencing depths at each nucleotide position determined in step 2, a local enrichment was calculated in a moving window of 30 nucleotides moving in steps of 15 nucleotides as (the mean depth at each nucleotide position in the 30-nucleotide window) divided by (the mean depth at each nucleotide position in a 3000-nucleotide window centered around the 30-nucleotide window).This results in an enrichment ratio value for every 15 nucleotides along the genome. Local enrichment in total (non-IP) samples were subtracted from those in IP samples. Enrichment for the control samples (*whiG* deletion strain) was subtracted from the enrichment in corresponding WT samples. Significance of enrichment values were calculated assuming normal distribution of the enrichment values. Genomic positions were ordered from low to high P values. Association of regions of enrichment with P values below 1e-4 with genes on the chromosome was done by simply listing genes left and right of the region. Rows of lower significance with the same context of genes were removed to leave the most significant row for each combination of left, right and *within* genes. Genes had to be in the right orientation and within 500 nucleotides of the enriched region for association with the region.

### Microarray analysis {#sec5.4.6}

WT *S. venezuelae* and the *ΔwhiG* null mutant were grown in triplicate 30 mL volumes of MYM and samples were collected at 2 h intervals from 8 to 20 h (26 mL at 8 h, 9 mL at 10 h, and 6 mL at subsequent time points). A 300 μL sample was removed at each time point to check the stage of development by phase contrast light microscopy, and to measure the optical density. Cells were harvested by centrifugation at 4°C, frozen in dry ice/ethanol, and ground in liquid nitrogen in a mortar and pestle that had been chilled in a dry ice/liquid nitrogen bath. Ground material was suspended in 2 mL TRIzol (Invitrogen) and divided equally between two 2 mL tubes; one was stored at −80°C as a backup and the other used for RNA isolation. Total RNA was isolated using the RNeasy mini kit (QIAGEN), largely according to the manufacturer's instructions, but with several modifications. Cell pellets were resuspended in TE buffer containing 15 mg/mL lysozyme and incubated for 60 min at room temperature. After addition of RNeasy RLT buffer samples were sonicated for 3 cycles of 20 s (Sanyo Soniprep 150, amplitude 18 microns), resting on ice for 1 min between bursts, then extracted twice with phenol-chloroform and once with chloroform. Extracts were then treated with ethanol and applied to the RNeasy mini columns for purification according to the supplied protocol, including an on-column DNaseI digestion step for 60 min at room temperature. Purified RNA was finally eluted in 300 μL RNase-free water. Single-strand reverse transcription (amplification) and indirect labeling of 10 μg total RNA were performed for hybridization to *Streptomyces* diS_div712a GeneChip arrays according to the manufacturer's published protocol (Affymetrix). GeneChips were washed and stained using a GeneChip fluidics workstation model 450 and scanned with a Gene Array Scanner.

The CEL files received from the scanner were read into the R package for statistical computing (<http://www.R-project.org/>) using the *ReadAffy* function of the *affy* package ([@bib35]). The *rma* function of the *affy* package was used to compute an *ExpressionSet* object from the CEL files. This *ExpressionSet* object contains the expression values (log2) for each gene in each CEL file. The function *lmFit* of the limma package ([@bib95]), along with a suitable design matrix, was used to combine replicate arrays into single coefficients of expressions for each gene at each time point or strain into an *MArrayLM* object. Expression values were retrieved from the *MArrayLM* object and used to generate the graphs shown in this paper.

### qRT-PCR {#sec5.4.7}

Mycelial pellets originating from 5 mL of culture grown in DNB medium were collected at appropriate time points, washed in PBS and resuspended in 900 μL lysis solution (400 μl phenol \[pH4.3\], 100 μL chloroform: isoamyl alcohol (24:1), and 400 μL RLT buffer \[QIAGEN\]) with lysing matrix B (MP Biomedicals) and homogenized using a FastPrep FP120 Cell Disruptor (Thermo Savant). Two pulses of 30 s of intensity 6.0 were applied with cooling down for 90 s on ice between pulses. Supernatants were centrifuged for 15 min, full-speed on a bench-top centrifuge at 4°C and then treated according to the instructions given in the RNEasy Kit (QIAGEN), including an on-column DNase I digestion step. This was followed by an additional DNase I treatment (Turbo DNA-free, Ambion) until samples were free of DNA contamination (determined by PCR amplification of *hrdB*). For qRT-PCR, equal amounts (500 ng) of total RNA from each sample was converted to cDNA using SuperScript II reverse transcriptase and random primers (Invitrogen). cDNA was then used as a template in qRT-PCR using the SensiFAST SYBR No-ROX kit (Bioline). Three technical replicates were performed for each sample. Primers vnz28820_qRT_F and vnz28820_qRT_R were used to amplify the σ^WhiG^ target gene *whiI*, and primers hrdBqRT_F and hrdBqRT_R were used to amplify the *hrdB* reference gene. To normalize for differing primer efficiency, a standard curve was constructed using chromosomal DNA. Melting curve analysis was used to confirm the production of a specific single product from each primer pair. qRT-PCR was performed using a CFX96 Touch instrument using hardshell white PCR plates (BioRad), sealed with thermostable film covers (Thermo). PCR products were detected with SYBR green fluorescent dye and amplified according to the following protocol: 95°C, 3 min, then 45 cycles at 95°C 5 s, 62°C 10 s and 72°C 7 s. Melting curves were generated at 65 to 95°C with 0.5°C increments. The BioRad CFX manager software was used to calculate mean starting quantity (SQ) values for *whiI* at each time point. These values were divided by mean SQ values measured for *hrdB* at corresponding time points, resulting in relative expression values. Relative expression values were normalized against the mean relative expression value of the WT at 10 hr, which was set to 1. This experiment, including RNA isolation, was repeated once independently.

### Western blotting {#sec5.4.8}

For analysis of protein levels, mycelial pellets originating from 5 mL of culture grown in DNB were resuspended in 2 mL of ice-cold wash buffer (20 mM Tris pH 8.0, 5 mM EDTA). Samples were centrifuged at 13,000 rpm for 1 min at 4°C. The supernatant was removed, and the pellet resuspended in 0.4 mL of sonication buffer (20 mM Tris pH 8.0, 5 mM EDTA, 1 x EDTA-free protease inhibitors \[Roche\]). Samples were sonicated at 4.5-micron amplitude for 7 rounds of 15 s, separated by 15 s of rest on ice. Lysed samples were then centrifuged at 13,000 rpm for 15 min at 4°C in order to remove cell debris. Total protein concentration was determined using a Bradford assay (Biorad). For analysis of RsiG or RsiG^∗^ levels, cell lysates were diluted to a final concentration of 0.7 mg/mL and loaded in triplicate into a microplate (ProteinSimple \#043-165), along with a polyclonal anti-RsiG antibody raised in rabbit (Cambridge Biosciences) diluted 1:50. For analysis of σ^WhiG^ levels, cell lysates were diluted to a final concentration of 0.2 mg/mL and loaded in triplicate, along with a polyclonal anti- σ^WhiG^ antibody raised in rabbit diluted 1:50. For both cases, protein levels were analyzed using the automated Western Blotting machine Wes (ProteinSimple, San Jose, CA) with the Wes-Rabbit (12 to 230 kDa) Master kit according to the manufacturer's instructions.

### Bacterial two-hybrid genomic library construction, screening, and analysis {#sec5.4.9}

Construction of bacterial two-hybrid genomic libraries was performed by BIO S&T (Saint-Laurent, Québec, Canada). Genomic DNA from *S. venezuelae* was sheared by sonication, then end-repaired and cloned into SmaI-digested pUT18C or pKT25. The ligation mix was transformed into competent DH10B *E. coli* cells and spread onto large agar plates, resulting in \> 329,200 colonies (40X coverage, assuming an insert size of 1 kb) for each library. Colonies on each plate were washed into tubes, pooled, and plasmids purified by maxi-prep. For quality control, 8-12 clones were randomly selected from each library. All clones selected were found to contain inserts, and the average size of each insert was 2.6 kb in the pUT18C library and 2.2 kb in the pKT25 library.

To construct the 'bait' vector containing σ^WhiG^ fusions, the coding region of *whiG* was amplified using primer set vnz26215_BACTH_F and vnz26215_BACTH_R, and cloned into BACTH vectors (pKT25, pKNT25, pUT18, pUT18C) digested with XbaI and Asp718 to create plasmids pIJ10907-pIJ10910. Each *whiG*-containing bait vector was co-electroporated with 0.25 μL of a working stock (0.1-0.5 μg/μL) of the appropriate corresponding genomic library into electrocompetent *E. coli* strain BTH101. Prior to plating, transformants were washed twice in M63 minimal medium, followed by resuspension in 1 mL of M63. In order to ensure that transformation efficiency was sufficient to ensure screening of all possible interactions, the total number of transformants was measured by plating 1 μL onto an LB agar plate containing appropriate antibiotics. The remaining transformation mixture was plated onto M63 agar containing 0.3% lactose, 0.5 mM IPTG, 40 μg/mL X-gal, and appropriate antibiotics. Positive clones were re-tested on MacConkey agar containing 1% maltose and appropriate antibiotics. Plasmid DNA was then isolated from positive clones, and inserts sequenced using primer sets T18seq_F and T18seq_R, T25seq_F and T25seq_R, NT25seq_F and NT25seq_R, or T18Cseq_F and T18Cseq_R. Out-of-frame clones were excluded from further analysis.

To test the interaction of full-length RsiG with σ^WhiG^, the coding sequence of *rsiG* was amplified using primers vnz19430_BACTH_F and vnz19430_BACTH_R and cloned into pKT25 and pUT18 vectors digested with XbaI and Asp718 to create plasmids pIJ10911 and pIJ10912. *E. coli* BTH101 was then co-transformed with 'T25' and 'T18' fusion plasmids. β-galactosidase activity was assayed in triplicate.

### Overexpression and copurification of the σ^WhiG^ -RsiG complex {#sec5.4.10}

To coexpress His-tagged σ^WhiG^ and non-tagged RsiG, *whiG* flanked by a 5′ EcoRI site and a 3′ HindIII site was amplified using primer set vnz26215_MCS1_F and vnz26215_MCS1_R, then cloned into multiple cloning site 1 (MCS1) of pCOLADuet-1. Next, *rsiG* flanked by a 5′ NdeI site and a 3′ KpnI site was amplified using primer set vnz19430_MCS2_F and vnz19430_MCS2_R and cloned into MCS2 of pCOLADuet-1 (with *whiG* already inserted at MCS1), resulting in the His-σ^WhiG^/RsiG coexpression construct pIJ10914.

Coexpression plasmid pIJ10914 was introduced into *E. coli* BL21(DE3) pLysS Rosetta for protein expression. This strain was grown at 30°C in LB medium to an OD~600~ of 0.5, then induced with 0.25 mM IPTG and incubated overnight at 16°C. Cells were harvested by centrifugation, then resuspended in Buffer A (50 mM Tris-Cl pH 8.0, 200 mM NaCl, 5% glycerol), and disrupted with a high-pressure homogenizer (Avestin). Cell debris was then removed by centrifugation (15,000 rpm, 4°C, 45 min). The supernatant was loaded onto a HisTrap Excel 1 mL column using a Pharmacia Biotech FRAC-100 FPLC system and eluted using a 0-500 mM imidazole gradient in Buffer A over 20 min. Fractions were analyzed by SDS-PAGE.

### Crystallization and structure determination of the σ^WhiG^-RsiG complex {#sec5.4.11}

The RsiG-σ^WhiG^ coexpression system encoding both full length proteins failed to crystallize. Hence, several co-expression constructs of the RsiG-σ^WhiG^ complex were purified for crystallization trials. A construct (pIJ10915) in which full length σ^WhiG^ was expressed with an N-terminally truncated RsiG (Δ26 RsiG) with a cleavable N-terminal His-tag produced two crystal forms. Notably, the N-terminal ∼50 residues are highly variable among the otherwise highly conserved RsiG homologs. For crystallization of this construct, the complex was purified similarly to the WT construct except cells were resuspended in a buffer (Buffer B) composed of 25 mM Tris-Cl pH 7.5, 300 mM NaCl, 5% glycerol. The supernatant was loaded onto a cobalt affinity column (Takara Bio USA) and the column washed with 300 mL of Buffer B. The protein complex was eluted using 100, 200, 300 and 500 mM imidazole steps. We later found that much longer washes with 1 l of Buffer B resulted in dissociation of the complex, which we realized stemmed from dissociation of the co-purifying c-di-GMP. For crystallization, the His-tag was removed from RsiG using a thrombin cleavage capture kit (Novagen, cat\#69022-3FRZ) and the protein complex was concentrated to 40 mg/mL with buffer exchanges (in 25 mM Tris pH 7.5, 150 mM NaCl, 5% glycerol, 1 mM DTT) to remove the CaCl~2~ present in the thrombin cleavage buffer. The complex was crystallized using the hanging drop vapor diffusion method at 22°C. Crystallization of the complex was effected by mixing the complex 1:1 with a solution composed of 0.1 M Tris Bicine pH 8.5, 0.03 M sodium nitrate, 0.03 M sodium phosphate, 0.03 M ammonium sulfate, 9% MPD, 10% PEG 1000 and 15% PEG 3350. Two crystal forms grew in the drops over a period of 1-3 months. The crystals were cryo-protected straight from the drop. Crystal form 1 takes the hexagonal space group, P6~4~ with a = b = 92.1 Å, c = 96.6 Å and γ = 120° while crystal form 2 is orthorhombic, P22~1~2~1~, with a = 79.8 Å, b = 97.3 Å and c = 204.6 Å. The crystals were cryo-protected straight from the drop

Molecular replacement using the σ^28^ structure from the σ^28^/FlgM complex failed. Hence, to obtain phase information, attempts were made to generate selenomethionone (semet) substituted σ^WhiG^-RsiG complex using the methionine inhibitory pathway ([@bib26]). However, this approach failed as semet substituted σ^WhiG^ was not soluble (the semet σ^WhiG^ was found in inclusion bodies) even when the induction was performed at lower temperatures (4°-15°C). However, the semet RsiG, which harbors an N-terminal His-tag, was soluble and could be purified from the cell lysate using cobalt affinity chromatography (Takara Bio USA). Because the RsiG construct used only contains three methionines, we generated an RsiG mutant in which Leu56 and Leu85 were substituted to methionines (pIJ10919) to obtain enough signal to phase the σ^WhiG^-RsiG complex. The semet substituted RsiG(L56M-L85M) protein was expressed at 15°C and the resultant cell pellet containing the induced protein was solubilized in 25 mM Tris-Cl pH 7.5, 300 mM NaCl, 5% glycerol. The cells were disrupted using a microfluidizer and the supernatant was loaded onto a cobalt affinity column (Takara Bio USA). The column was washed with 200 mL of the buffer and the protein eluted using 100, 200, 300 and 500 mM imidazole steps. The His-tag was removed from the semet RsiG(L56M-L85M) protein using a thrombin cleavage capture kit (Novagen, cat\#69022-3FRZ). To generate non-semet σ^WhiG^ to form a complex with the semet RsiG(L56M-L85M) protein we utilized a construct in which σ^WhiG^ had a cleavable N-terminal His-tag (pIJ10920). The protein was expressed at 15°C overnight. The cells were solubilized in 25 mM Tris-Cl pH 7.5, 300 mM NaCl, 5% glycerol and the supernatant loaded onto a cobalt affinity column (Takara Bio USA). The column was washed with 300 mL of the buffer and σ^WhiG^ eluted with buffer B with 300 mM imidazole. The His-tag was removed from σ^WhiG^ using a thrombin cleavage capture kit (Novagen, cat\#69022-3FRZ). To generate the complex, σ^WhiG^ was mixed 1:1 with RsiG(L56M-L85M) and subjected to size exclusion chromatography using a superdex 75 (S75) Sepharose column. A small amount of σ^WhiG^ -semetRsiG(L56M-L85M) complex was obtained and the complex crystallized using the same solution and conditions as the WT complex. Several σ^WhiG^-semetRsiG(L56M-L85M) preparations were utilized in crystallization attempts but only one produced small crystals of the hexagonal form and one of these crystals was used to collect single wavelength anomalous diffraction (SAD) data to 2.7 Å at the Advanced Light Source (ALS) Beamline 8.3.1. Data for the WT crystals, hexagonal and orthorhombic, were also collected at ALS beamline 8.3.1. All X-ray intensity data were integrated in MOSFLM and scaled using SCALA ([@bib61]). Autosol in Phenix was used to locate heavy atoms sites with the semet SAD data, perform density modification and generate an initial electron density map. The model was built into the experimental SAD map using O ([@bib52]) and minimally refined to an R~free~ of 31%. The c-di-GMP dimer was evident in this initial model. The structure contains one complex (one σ^WhiG^ and one RsiG) in the asymmetric unit (ASU). The partially refined model was then used in molecular replacement (MR) against the high-resolution hexagonal dataset. After multiple rounds of building in O and refinement with Phenix ([@bib52], [@bib1]), the model converged to R~work~/R~free~ values of 19.5%23.8% to 2.08 Å resolution. The final model includes RsiG residues 50-198 and σ^WhiG^ residues 24-183; 216-275, two c-di-GMP molecules and 60 solvent molecules.

The second crystal form contained three complexes in the ASU and the structure was solved by MR using Phaser with the 2.08 Å structure (minus the solvent and c-di-GMP) as the search model. Three clear solutions were obtained, and the structure was optimized by building in O and refinement in Phenix ([@bib52], [@bib1]). Clear density for the same c-di-GMP dimer as in the hexagonal crystal form was observed in each of the three complexes after one round of refinement. After c-di-GMP addition, and further refinement, the model converged to final R~work~/R~free~ values of 20.9%/27.9% to 3.0 Å resolution. The final model includes RsiG residues 36-199 and σ^WhiG^ residues 24-183, 216-275 for one complex, RsiG residues 40-199 and σ^WhiG^ residues 24-183, 216-275 for the second complex and RsiG residues 41-199 in and σ^WhiG^ residues 24-183, 216-275 for the third structure. Each complex also contains an identically bound c-di-GMP dimer.

### Determination of the affinity and specificity of c-di-GMP for RsiG and RsiG-σ^WhiG^ by fluorescence polarization (FP) {#sec5.4.12}

To measure c-di-GMP binding to RsiG and RsiG-σ^WhiG^, 2′-O-(6-\[Fluoresceinyl\]aminohexylcarbamoyl)-cyclic diguanosine monophosphate (2′-Fluo-AHC-c-di-GMP) (BioLog), was used as a fluoresceinated reporter ligand. This molecule is conjugated via a 9-atom spacer to one of the 2′ hydroxyl groups of the c-di-GMP. This ligand was chosen as the structure shows that one ribose hydroxyl from each c-di-GMP would be solvent exposed when bound to RsiG and the RsiG-σ^WhiG^ complex. 2′-O-(6-\[Fluoresceinyl\]aminohexylcarbamoyl)-cyclic diadenosine monophosphate (2′-Fluo-AHC-c-di-AMP) (BioLog) was also used in binding studies to assess specificity of RsiG for c-di-GMP. The experiments were all carried out in a buffer of 150 mM NaCl and 25 mM Tris-HCl pH 7.5, which contained 1 nM 2′-Fluo-AHC-c-di-GMP or 2′-Fluo-AHC-c-di-AMP at 25°C. Increasing concentrations of RsiG alone (prepared using pIJ10917), or RsiG∗ alone (prepared using pIJ10918), or a mixture of equimolar concentrations of RsiG and σ^WhiG^, were titrated into the reaction mixture to obtain their respective binding isotherms. The resultant data were plotted using KaleidaGraph and the curve fit to deduce binding affinities. Note, each batch of these *E. coli* produced proteins had some c-di-GMP contaminant, which efforts were made to remove, however, variability between batches was noted. Three technical repeats were performed for each curve and the standard errors from the three affinities were determined.

### Time-lapse imaging of S. venezuelae {#sec5.4.13}

Cultures were grown in 30 mL DNB until fully differentiated (24-30 h). Before imaging, spores were prepared from the hypersporulating strain *S. venezuelae ermE^∗^-whiG* by diluting the culture 1:50 in DNB medium. For all other strains, spores were prepared by centrifuging 1 mL of culture at 2000 rpm for 1 min, then diluting supernatant 1:20 in DNB medium. For all strains, 200 μL of prepared spores were loaded into the cell loading well of a prepared B04A microfluidic plate (Merck-Millipore). The ONIX manifold was then sealed to the B04A plate before transferring to the environmental chamber, pre-incubated at 30°C. Spores were loaded onto the plate at 8 psi for 5 s. Medium flow was set at 2 psi throughout the experiment, first with fresh DNB for 3 h, followed by sterile-filtered spent DNB medium derived from a shaking culture of *S. venezuelae* pKF351/pIJ10257.

Imaging was conducted using a Zeiss Axio Observer.Z1 widefield microscope equipped with a sCMOS camera (Hamamatsu Orca FLASH 4), a metal-halide lamp (HXP 120V), a hardware autofocus (Definitive Focus), a 96-well stage insert, an environmental chamber, a 100x 1.46 NA Oil DIC objective and the Zeiss 46 HE shift free (excitation500/25 nm, emission 535/30 nm) filter set ([@bib88], [@bib89], [@bib11]). Image collection began after clear signs of spore germination were observed (1-2 hr) and images were taken every 20 min. DIC images were captured with a 150 ms exposure time, YFP images were captured with a 350 ms exposure time. In all experiments, multiple x/y positions were imaged for each strain. Representative images were processed using the Fiji Software package (<http://fiji.sc/>; [@bib88]).

Quantification and Statistical Analysis {#sec5.5}
---------------------------------------

Prism software (GraphPad) was used for statistical analyses. Data in [Figures 4](#fig4){ref-type="fig"}B--4E and [Figure 7](#fig7){ref-type="fig"}D were derived from triplicates and are represented as mean ± Standard Error.

Data and Code Availability {#sec5.6}
--------------------------

The accession number for the ChIP-seq data reported in this paper is ArrayExpress: E-MTAB-8160. The accession number for the microarray transcriptional profiling data is ArrayExpress: E-MTAB-8114. The accession numbers for the crystal structures are PBD: 6PFJ, 6PFV.
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